These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 15152633)

  • 1. FDA head wanted, wimps need not apply.
    Miller HI
    Nat Rev Drug Discov; 2004 May; 3(5):459. PubMed ID: 15152633
    [No Abstract]   [Full Text] [Related]  

  • 2. FDA leadership picks may stress safety over swift approval.
    Dorans K
    Nat Med; 2009 May; 15(5):466. PubMed ID: 19424185
    [No Abstract]   [Full Text] [Related]  

  • 3. Mr. Outside moves inside. Daniel Troy fought the FDA for years; now he's helping to run it.
    Schultz S
    US News World Rep; 2003 Mar; 134(9):63-5. PubMed ID: 12688015
    [No Abstract]   [Full Text] [Related]  

  • 4. Eat, drink and be wary.
    Rosenberg D
    Newsweek; 2003 Dec 29-2004 Jan 5; 143(1):80. PubMed ID: 14723092
    [No Abstract]   [Full Text] [Related]  

  • 5. Will politics sidetrack FDA reform?
    Gatty B
    Formulary; 1995 Aug; 30(8):476, 475. PubMed ID: 10151736
    [No Abstract]   [Full Text] [Related]  

  • 6. The FDA is no place for politics.
    Nat Struct Mol Biol; 2006 May; 13(5):379. PubMed ID: 16738601
    [No Abstract]   [Full Text] [Related]  

  • 7. Memo to FDA head: IT upgrade required.
    Nat Biotechnol; 2005 May; 23(5):507. PubMed ID: 15877051
    [No Abstract]   [Full Text] [Related]  

  • 8. A familiar face at the FDA.
    Nat Med; 2005 Nov; 11(11):1125. PubMed ID: 16270047
    [No Abstract]   [Full Text] [Related]  

  • 9. What ails the FDA?
    Marcus DM
    N Engl J Med; 2005 Jun; 352(24):2554. PubMed ID: 15962405
    [No Abstract]   [Full Text] [Related]  

  • 10. Another long leaderless period in store for FDA.
    Frantz S
    Nat Rev Drug Discov; 2004 Apr; 3(4):289. PubMed ID: 15124619
    [No Abstract]   [Full Text] [Related]  

  • 11. Chess game at the FDA.
    Kennedy D
    Science; 2005 Oct; 310(5748):589. PubMed ID: 16254152
    [No Abstract]   [Full Text] [Related]  

  • 12. A message to the new FDA Commissioner.
    Hatch OG
    Food Drug Law J; 1999; 54(1):5-11. PubMed ID: 11757555
    [No Abstract]   [Full Text] [Related]  

  • 13. Confronting the future of the FDA.
    Serafini MW
    Natl J (Wash); 1996 Dec; 28(50):2704-5. PubMed ID: 10163877
    [No Abstract]   [Full Text] [Related]  

  • 14. Change coming to FDA. Law should speed approvals, but critics say it's not enough.
    Hensley S
    Mod Healthc; 1997 Nov; 27(46):28. PubMed ID: 10174355
    [No Abstract]   [Full Text] [Related]  

  • 15. FDA appointee faces angry, demoralized staff.
    Fox JL
    Nat Biotechnol; 2002 Nov; 20(11):1065. PubMed ID: 12410237
    [No Abstract]   [Full Text] [Related]  

  • 16. The big gap at the FDA.
    Stipp D
    Fortune; 2002 Jul; 146(2):113-4, 116. PubMed ID: 12141178
    [No Abstract]   [Full Text] [Related]  

  • 17. FDA rulemaking after the 104th Congress: major rules enter the twilight zone of review.
    O'Reilly JT
    Food Drug Law J; 1996; 51(4):677-95. PubMed ID: 11797735
    [No Abstract]   [Full Text] [Related]  

  • 18. FDA a main culprit in delayed access to technology.
    Albertson D
    MLO Med Lab Obs; 1995 Aug; 27(8):23-4. PubMed ID: 10144934
    [No Abstract]   [Full Text] [Related]  

  • 19. A significant day for women's health and the FDA.
    Howes J; Bass M
    J Gend Specif Med; 1998; 1(2):14-5, 17. PubMed ID: 11281005
    [No Abstract]   [Full Text] [Related]  

  • 20. Reagan is leaving his mark on the Food and Drug Administration.
    Kosterlitz J
    Natl J (Wash); 1985 Jul; 17(27):1568-72. PubMed ID: 10271744
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.